Depression News and Research

Latest Depression News and Research

Virtual follow-up visits for hypertension care just as effective as in-person office visits

Virtual follow-up visits for patients with hypertension appeared to be just as effective as in-person office visits in helping maintain blood pressure control.

24 May 2018

Social isolation could increase risk of death, hospitalizations for heart failure patients

Patients with heart failure who felt socially isolated were much more likely to die or be hospitalized than more socially connected patients, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.

23 May 2018

Slower rates of stimulation may be more effective in brain therapy, suggests research

One of the promising non-invasive brain therapeutic methods is the repetitive transcranial magnetic stimulation. During such a procedure, a magnetic coil is placed near the head of the patient and a magnetic pulse is transmitted to a specific damaged region of the brain.

23 May 2018

Yoghurt before a meal packed with health benefits

A new study has shown that consuming a small pot of yoghurt each day can be beneficial for health in more ways than one.

22 May 2018

Specific patterns of fat distribution linked to metabolic disease, shows study

Specific patterns of fat distribution are linked to the presence of Coronary Heart Disease and Type 2 Diabetes, according to a new study published in Obesity.

22 May 2018

Scientists identify cell types underlying schizophrenia

Scientists at Karolinska Institutet in Sweden and University of North Carolina, USA, have identified the cell types underlying schizophrenia in a new study published in Nature Genetics. The findings offer a roadmap for the development of new therapies to target the condition.

21 May 2018

Brain stimulation shows promise in treating obesity by reducing food cravings

Stimulating the brain to alter its intrinsic reward system shows promise in the treatment of obesity, according to results presented in Barcelona at the European Society of Endocrinology annual meeting, ECE 2018.

21 May 2018

AUA recommends use of UroLift System for managing lower urinary tract symptoms attributed to BPH

NeoTract, a wholly owned subsidiary of Teleflex Incorporated focused on addressing unmet needs in the field of urology, today announced that the American Urological Association has recommended the use of the UroLift System as a standard of care treatment for lower urinary tract symptoms due to benign prostatic hyperplasia.

18 May 2018

Brain abnormality linked to general risk for mental illness

A new study by researchers at Duke University reports an abnormality in visual regions of the brain that is associated with a person's general risk for mental illness.

17 May 2018

Pfizer announces Phase 3 study results of LYRICA Oral Solution CV for pediatric epilepsy patients

Pfizer Inc. announced today positive top-line results of a Phase 3 study examining the use of LYRICA® Oral Solution CV as adjunctive therapy for partial onset seizures in pediatric epilepsy patients one month to less than four years of age.

17 May 2018

Male depression reduces the chances of getting pregnant, finds new study

A new study has shown that among couples being treated for infertility, male depression was associated with lower pregnancy rates.

17 May 2018

Researchers highlight need for transgender-inclusive healthcare providers

More should be done to take care of the mental health of transgender people in the US, a new survey carried out in Colorado indicates.

16 May 2018

National trial shows how high-tech strategies may change the field of mental health

A national research trial initiated by UT Southwestern in 2012 is generating the first set of results this year that provides an early glimpse into how such high-tech strategies may change the field of mental health.

16 May 2018

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection.

16 May 2018

Mood disturbances and depression linked to disrupted sleep routines finds study

According to a new study, people who routinely had a disrupted night’s sleep had an altered 24 hour cycle were more at risk of getting mood disorders, depression, bipolar disease. They score low on happiness and feel more lonely say researchers. This study, explain researchers, is vital in understanding the balance between rest and activity. The study appeared in the latest issue of the journal Lancet Psychiatry.

16 May 2018

Mindfulness-based stress reduction may motivate people to move, shows study

A meditation and stress reduction program may be as effective at getting people to move more as structured exercise programs, according to a new study led by an Iowa State University researcher.

15 May 2018

Depression and anxiety strongly linked with autoimmune thyroiditis, shows study

There is a strong link between depression and anxiety disorders and autoimmune thyroiditis, a chronic thyroid condition affecting approximately 10 percent of the population. Scientists at Friedrich-Alexander-Universität Erlangen-Nürnberg have now proven that special treatment could help many sufferers, especially women.

15 May 2018

Depression screening should be at the forefront of CAD treatment, say researchers

For clinicians providing comprehensive care to patients with coronary artery disease, proactive depression screening may not always rank high on the list of first-priority concerns.

15 May 2018

Gene variant may be linked to worse psychiatric symptoms in TBI patients

A variant of the APOE gene may be linked to worse psychiatric symptoms in people who have had a traumatic brain injury, found a Veterans Affairs San Diego Healthcare System study. Study participants with both the gene variant and at least one TBI had more severe symptoms of PTSD, anxiety, and depression than comparison participants.

14 May 2018

High job strain associated with increased risk of common mental disorders

Workplaces that reduce job strain could prevent up to 14 percent of new cases of common mental illness from occurring, according to new research led by the Black Dog Institute.

14 May 2018

Depression News and Research

Latest Depression News and Research

Virtual follow-up visits for hypertension care just as effective as in-person office visits

Social isolation could increase risk of death, hospitalizations for heart failure patients

Slower rates of stimulation may be more effective in brain therapy, suggests research

Yoghurt before a meal packed with health benefits

Specific patterns of fat distribution linked to metabolic disease, shows study

Scientists identify cell types underlying schizophrenia

Brain stimulation shows promise in treating obesity by reducing food cravings

AUA recommends use of UroLift System for managing lower urinary tract symptoms attributed to BPH

Brain abnormality linked to general risk for mental illness

Pfizer announces Phase 3 study results of LYRICA Oral Solution CV for pediatric epilepsy patients

Male depression reduces the chances of getting pregnant, finds new study

Researchers highlight need for transgender-inclusive healthcare providers

National trial shows how high-tech strategies may change the field of mental health

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

Mood disturbances and depression linked to disrupted sleep routines finds study

Mindfulness-based stress reduction may motivate people to move, shows study

Depression and anxiety strongly linked with autoimmune thyroiditis, shows study

Depression screening should be at the forefront of CAD treatment, say researchers

Gene variant may be linked to worse psychiatric symptoms in TBI patients

High job strain associated with increased risk of common mental disorders

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Depression News and Research

Latest Depression News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in